Sterling Partners Welcomes Q-Centrix LLC into Portfolio

January 9, 2014

Sterling Partners, a growth-oriented investment firm with more than $5 billion of assets under management, today announced that it has partnered with Q-Centrix LLC, a leading outsourced healthcare outcomes-data provider focused exclusively on serving the quality departments of acute care hospitals. Terms of the transactions were not disclosed.

“Q-Centrix has quickly become a national leader in core measure and registry abstraction services over the last several years across the United States, serving hundreds of client healthcare facilities and their patients,” said Dan Hosler, principal at Sterling Partners. “We are excited to help Q-Centrix continue its growth trajectory, as it benefits from the health care system’s shift to an increasingly quality-based reimbursement model, which creates regulatory and market incentives to accurately capture, report and improve quality measures.”

Rob Schwager, founder and CEO of Q-Centrix, said, “Sterling’s understanding of the healthcare industry and experience working successfully with management teams to build great companies convinced us Sterling Partners was the best choice to help scale our business. We are excited to work with Sterling as we pursue Q-Centrix’s vision of improving healthcare quality and patient health outcomes.”

About Q-Centrix

Q-Centrix is the largest exclusive provider of outsourced retrospective and concurrent Core Measure and Registry data abstraction for acute care hospitals. The company uses proprietary technology and a team of outsourced abstractors to collect data for chart-based core measures and registry collection from hospital record systems. With specialization of knowledge and process, Q-Centrix is able to deliver levels of accuracy, dependability and cost efficiency which exceed that of typical in-house abstracting staff.  For more information visit: www.Q-Centrix.com.